Categories
Canada Popular Stocks US Market

Tetra Bio-Pharma Receives Compliant Rating on Inspection from Health Canada

Sumary of Tetra Bio-Pharma Receives Compliant Rating on Inspection from Health Canada:

  • Or the “Company”) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce that its contract manufacturing facility, Quantum Pharma Inc., received a notice of compliance for its Drug Establishment License (DEL) following an audit by the Drug GMP Inspection Program of Health Canada…
  • The manufacturing of any prescription drug is a complex operation that takes expertise and dedication to achieve high quality standards.”..
  • Since then, Tetra has continuously improved its quality management system to ensure compliance with Health Canada’s GMP requirements…
  • The inspection took place in February 2021 and during this period, Tetra demonstrated to Health Canada that it can manufacture drugs, such as QIXLEEF™, in compliance with the requirements for a prescription drug…
  • Guy Chamberland, added, “Maintaining a Compliant Rating (C) for a DEL is not an easy task as it is the recognition of the pharmaceutical GMP quality process by Health Canada…
  • This is another sign to shareholders that we are committed to working and operating by the rules set by drug regulators like Health Canada and the U.S…
  • Tetra Bio-Pharma (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1) is a biopharmaceutical pioneer in immunomodulator drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers…
  • Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology….

Want to know more click here go to source.